Skip to main content

Table 3 Effect of diabetes mellitus on cardioprotection by pre- and post-conditioning

From: Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning

Species

DM

PC stimuli

First author

Journal

 

type

duration

   

Preserved protection

PC

Rat (SD)

1

4 w

3x 5I5R

Shi-Ting

Biomed Pharmacother 2010

Rat (Wistar)

2

11-12 m

3x 5I5R

Liu

Circulation 1993

Rat (Wistar)

1

6 w

LiCl 20 mM, IND 1 μM, SB 3 μM

Yadav

Mol Cell Biochem 2010

Rat (Zucker diabetic fatty)

2

(10-12 w old)

Rosiglitazone 3 mg/kg for 1 week

Yue

Diabetes 2005

Rat (OLETF)

2

(25-30 w old)

SB 1.2 mg/kg

Miki

Diabetes 2009

Rat (Goto-Kakizaki)

2

 

3x 5I10R

Tsang

Diabetes 2005

Rat (Goto-Kakizaki)

2

(12 w old)

WY 1 mg/kg

Bulhak

Am J Physiol 2009

Rat (Goto-Kakizaki)

2

 

olprinone 10 μg/kg

Matsumoto

Cardiovasc Drug Ther 2009

Mice (ob/ob)

2

(8-10 w old)

Metformin 125 μg/kg

Calvert

Diabetes 2008

Mice (KK-Ay)

2

(6 w old)

Pioglitazone 25 mg/kg for 2 week

Honda

J Mol Cell Cardiol 2008

PostC

     

Rat (SD)

1

2 w

SB 0.6 mg/kg

Gross

Diabetes 2007

Rat (Wistar)

1

4 w

SB 3 μM

Ghaboura

Basic Res Cardiol 2011

Rat (OLETF)

2

(25-30 w old)

BIO 0.08 mg/kg

Hotta

Circ Res 2010

Rat (Goto-Kakizaki)

2

 

Metformin 50 μM

Bhamra

Basic Res Cardiol 2008

Mice (ob/ob)

2

(8-10 w old)

Metformin 125 μg/kg

Calvert

Diabetes 2008

Impaired protection

PC

Dog

1

3 w

4x 5I5R

Kersten

Am J Physiol 2000

Dog

1

3 w

Diazoxide 2.5 mg/kg

Kersten

Am J Physiol 2001

Rabbit (NZ)

1

4-5 w

3x 2I2R

Nieszner

Exp Clin Endocrinol Diabetes 2002

Rat (SD)

1

8 w

3x 5I5R

Wang

Biomedicine Aging Pathol 2011

Rat (Wistar)

1

6 w

5I5R

Galagudza

Neurosci Behav Physiol 2007

Rat (Wistar)

1

6 w

4x 5I5R

Yadav

Mol Cell Biochem 2010

Rat (Wistar)

2

10-12 w

Metformin 200 mg/kg for 3 days

Kravchuk

Exp Diabetes Res 2011

Rat (Zucker obese)

2

(10-12 w old)

5I5R, Diazoxide 10 mg/kg

Katakam

Am J Physiol 2007

Rat (Zucker diabetic fatty)

2

(16 w old)

4x 2I3R

Kristiansen

Diabetologia 2004

Rat (OLETF)

2

(25-30 w old)

EPO 5000 U/kg

Miki

Diabetes 2009

Rat (OLETF)

2

(25-30 w old)

EPO 5000 U/kg, DADLE 1 mg/kg

Hotta

Circ Res 2010

Rat (Goto-Kakizaki)

2

(16 w old)

4x 2I3R

Kristiansen

Diabetologia 2004

Rat (Goto-Kakizaki)

2

 

5I10R, 2x 5I10R

Tsang

Diabetes 2005

Rat (Goto-Kakizaki)

2

(16-18 w old)

EPO 5000 U/kg

Miki

Diabetes 2009

Rat (Goto-Kakizaki)

2

 

isoflurane 1.0%

Matsumoto

Cardiovasc Drug Ther 2009

PostC

Rat (SD)

1

2 w

Morphine 0.3 mg/kg

Gross

Diabetes 2007

Rat (SD)

1

4-5 w

3x 20sR20sI, sevoflurane 1.0 MAC

Drenger

Anesthesiology 2011

Rat (Wistar)

1

4 w

Darbopoetin alpha 5 μg/kg

Ghaboura

Basic Res Cardiol 2011

Mice

1

2 w

3x 10sR10sI, 6x 10sR10sI

Przyklenk

Antioxid Redox Signal 2011

Mice (ob/ob)

2

(8-10 w old)

6x 10sR10sI

Bouhidel

Am J Physiol 2008

Mice (ob/ob)

2

(12-14 w old)

3x 10sR10sI, 6x 10sR10sI

Przyklenk

Antioxid Redox Signal 2011

Mice (ob/ob)

2

(10-12 w old)

6x 10sR10sI

Zhu

J Cell Mol Med 2011

Mice (KK-Ay)

2

(6 w old)

Pioglitazone 25 mg/kg

Honda

J Mol Cell Cardiol 2008

Late PC

Rabbit (NZ white)

1

5-6 w

5I24hR

Ebel

Pflugers Arch 2003

  1. IND indirubin-3 monooxime (a GSK-3β inhibitor), SB SB216763 (a GSK-3β inhibitor), WY 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (a PPAR-α agonist), BIO 6-bromo-indirubin-3'-oxime (a GSK3β inhibitor), EPO erythropoietin, DADLE [D-Ala2, D-Leu5]-enkephalin acetate (a δ-opioid receptor agonist), 5I5R 5-min ischemia/5-min reperfusion, 5I24hR 5-min ischemia/24-hour reperfusion, 10sR10sI 10-second reperfusion/10-second ischemia, MAC minimal alveolar concentration, w weeks, m months.